InMode remains a 'Hold' as its cheap valuation is offset by margin decay, flat growth, and strategic uncertainty. INMD faces declining gross margins (from mid-80s percent to 75–77%) and slowing ...
InMode Ltd. remains a global leader in minimally-invasive aesthetics, with proprietary RF and laser technologies and a strong international growth trajectory. I maintain a Strong Buy rating for INMD, ...
There were two different stories for InMode (NASDAQ: INMD) in 2022. In the first half of the year, the medical device stock plunged 68%. However, in the second half, InMode roared back, with its ...
InMode (NASDAQ:INMD) is gearing up to announce its quarterly earnings on Tuesday, 2026-02-10. Here's a quick overview of what investors should know before the release. Analysts are estimating that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results